The "Byron Nash Renal Medullary Carcinoma Awareness Act of 2023" aims to raise awareness about Renal Medullary Carcinoma (RMC), a rare and aggressive form of kidney cancer that primarily affects individuals with sickle cell trait. The bill includes provisions for funding research, education, and outreach programs to increase understanding of RMC among healthcare providers and the public. It also seeks to improve early detection, treatment options, and support services for those affected by RMC. This legislation could lead to better outcomes for individuals diagnosed with this rare cancer and help address disparities in healthcare access and outcomes related to RMC.
2023-01-09: Introduced in House
2023-01-09: Referred to the House Committee on Energy and Commerce.
2023-01-20: Referred to the Subcommittee on Health.
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..